- Home
- EBON vs LSTA Comparison
EBON vs LSTA Comparison
Compare EBON & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBON
- LSTA
- Stock Information
- Founded
- EBON 2010
- LSTA 1980
- Country
- EBON China
- LSTA United States
- Employees
- EBON N/A
- LSTA N/A
- Industry
- EBON Semiconductors
- LSTA Misc Health and Biotechnology Services
- Sector
- EBON Technology
- LSTA Health Care
- Exchange
- EBON Nasdaq
- LSTA Nasdaq
- Market Cap
- EBON 34.4M
- LSTA 31.2M
- IPO Year
- EBON 2020
- LSTA N/A
- Fundamental
- Price
- EBON $5.42
- LSTA $2.55
- Analyst Decision
- EBON
- LSTA Strong Buy
- Analyst Count
- EBON 0
- LSTA 1
- Target Price
- EBON N/A
- LSTA $15.00
- AVG Volume (30 Days)
- EBON 12.4K
- LSTA 24.3K
- Earning Date
- EBON 01-01-0001
- LSTA 02-27-2025
- Dividend Yield
- EBON N/A
- LSTA N/A
- EPS Growth
- EBON N/A
- LSTA N/A
- EPS
- EBON N/A
- LSTA N/A
- Revenue
- EBON $3,591,648.00
- LSTA N/A
- Revenue This Year
- EBON N/A
- LSTA N/A
- Revenue Next Year
- EBON N/A
- LSTA N/A
- P/E Ratio
- EBON N/A
- LSTA N/A
- Revenue Growth
- EBON N/A
- LSTA N/A
- 52 Week Low
- EBON $5.34
- LSTA $2.19
- 52 Week High
- EBON $14.19
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- EBON 41.32
- LSTA 42.39
- Support Level
- EBON $5.38
- LSTA $2.41
- Resistance Level
- EBON $5.50
- LSTA $2.66
- Average True Range (ATR)
- EBON 0.26
- LSTA 0.19
- MACD
- EBON 0.02
- LSTA 0.01
- Stochastic Oscillator
- EBON 12.31
- LSTA 42.06
About EBON Ebang International Holdings Inc.
Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services. Its geographic regions are Mainland China, Australia, and Other countries and regions.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.